call Toll Free (US/Canada): +1 866 658 6826 | call+1 425 320 4776 | call (UK): +44 1865 60 0662 | call (Ind): +91 9096278110 | email info(@)blueweaveconsulting.com
Home | About Us | Career | Services | Blog | Contact Us
Blueweave
Herpes Simplex Virus Treatment Market
Inquire Before Buying Request for Sample

Herpes Simplex Virus Treatment Market

Home Healthcare And Pharmaceutical Herpes Simplex Virus Treatment Market

Herpes Simplex Virus (HSV) Treatment Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Type (Herpes Simplex Virus-1 Infection, Herpes Simplex Virus-2 Infection); By Drug Type (Acyclovir, Valacyclovir, Famciclovir); By Distribution Channel (Hospital Pharmacies, Drug Store & Retail Pharmacies, Online Providers); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

  • Published Date: July 2023
  • Report ID: BWC23615
  • Available Format: PDF
  • Page: 400

Report Overview

Increasing prevalence of herpes simplex virus (HSV) infections and rising development of HSV testing and medications are projected to propel the expansion of the global herpes simplex virus (HSV) treatment market during the forecast period between 2023 and 2029.

Global Herpes Simplex Virus (HSV) Treatment Market - Industry Trends & Forecast Report, 2029

Global herpes simplex virus (HSV) treatment market size was estimated at USD 1.73 billion in 2022. During the forecast period between 2023 and 2029, the size of global herpes simplex virus (HSV) treatment market is projected to grow at a CAGR of 3.83% reaching a value of USD 2.17 billion by 2029. Major growth drivers for the global herpes simplex virus (HSV) treatment market include an increasing prevalence of herpes infections, rising awareness about available treatment options, and the growing demand for effective therapies. Increasing adoption of antiviral drugs and the development of novel treatment approaches are further contributing to market growth. Herpes simplex is a prevalent strain of the herpes virus that impacts a substantial portion of the global population, with an estimated 3.7 billion individuals affected. This infection exhibits a high level of contagiousness and can be transmitted through various bodily fluids such as saliva, vaginal secretions, or semen, often without the carrier's knowledge. Also, there has been a growing incidence of human herpesvirus lytic reactivation in COVID-19 patients, including those who have been vaccinated during the forecast period.

Herpes Simplex Virus (HSV) Treatment Market

Global Herpes Simplex Virus (HSV) Treatment Market – Overview

The global herpes simplex virus (HSV) treatment market refers to the collective market for pharmaceutical products, therapies, and interventions used in the management and treatment of herpes infections caused by the herpes simplex virus. This market encompasses various treatment options, including antiviral medications, topical creams, vaccines, and other therapeutic approaches aimed at reducing the severity of outbreaks, alleviating symptoms, and suppressing viral replication. The market is driven by the increasing prevalence of herpes infections globally, the growing demand for effective treatment options, and ongoing research and development efforts to improve therapeutic outcomes.

Global Herpes Simplex Virus (HSV) Treatment Market

Growth Drivers

Increasing Prevalence of Herpes Simplex Virus (HSV) Infections

With an increasing focus on symptom management and transmission prevention, patients are seeking HSV therapies to address their needs and enhance sexual health awareness. Healthcare services, including HSV treatment, have also become more accessible in developing countries due to higher healthcare expenditure. This improved accessibility has resulted in an upsurge in demand for HSV treatments. Consequently, the growing prevalence of HSV infections is driving the need for treatment and medication, thereby fueling the expansion of the market for herpes simplex virus (HSV) treatment.

Increasing Development of HSV Testing and Medications

A multitude of educational initiatives have played a crucial role in raising awareness about herpes infections and the treatment options available. As a result, there has been an increase in the acceptance of diagnosis and treatment among individuals. The growing recognition of herpes infections has led to a higher demand for effective treatments, particularly in developed countries. Additionally, the expanded availability of commonly used herpes medications in underdeveloped and developing nations has prompted market players to offer more advanced medications in these regions. Consequently, these factors are driving the growth of the market during the forecast period.

Restraints

Potential Side Effects of Anti-HSV Drugs

The use of suppressive acyclovir treatments has led to the development of herpes simplex virus (HSV) strains that are resistant to acyclovir. This poses a concern because the alternative anti-herpes medications, cidofovir and foscarnet, are comparatively more toxic than acyclovir. An article in the literature highlights the emergence of acyclovir-resistant HSV in an infant undergoing long-term suppressive acyclovir treatment. Another study describes a case of a 10-day-old infant with acyclovir-resistant HSV infection in the larynx. Therefore, the potential side effects associated with prolonged use of herpes medications may impede the growth of the market during the forecast period.

Impact of COVID-19 on Global Herpes Simplex Virus (HSV) Treatment Market

COVID-19 pandemic had a dual impact on the global herpes simplex virus (HSV) treatment market. On the one hand, the increased focus on healthcare and hygiene practices raised awareness about the importance of managing infectious diseases like HSV. It increased the demand for HSV treatments. On the other hand, the diversion of healthcare resources and disruption of supply chains as the pandemic posed challenges for accessing and delivering HSV treatments. Also, the prioritization of COVID-19-related research and development temporarily slowed down advancements in HSV treatment options. The overall impact of COVID-19 on the global herpes simplex virus (HSV) treatment market remains complex and may vary across regions.

Global Herpes Simplex Virus (HSV) Treatment Market

Segmental Coverage

Global Herpes Simplex Virus (HSV) Treatment Market – By Type

By type, the global herpes simplex virus (HSV) treatment market is bifurcated into Herpes Simplex Virus-1 Infection and Herpes Simplex Virus-2 Infection segments. Herpes Simplex Virus-1 Infection segment held a higher share in the global herpes simplex virus market in 2022 due to the escalating prevalence of HSV-1 infection within the population. The market is further propelled by the increasing risk associated with HSV-1 transmission, which can occur through various means such as contact with the virus through saliva, sores, or even through oral-genital contact. Also, the mounting burden of Herpes Simplex Virus-1 encephalitis (HSE), a rare neurological disorder caused by the virus, is anticipated to drive the growth of this segment. According to the National Organization for Rare Disorders (NORD), HSE affects males and females in equal numbers and typically manifests during early childhood or adulthood. This disorder accounts for approximately 10 percent of reported encephalitis cases and nearly 2,000 reported cases of acute encephalitis in the United States.

Herpes Simplex Virus (HSV) Treatment Market Size

Global Herpes Simplex Virus (HSV) Treatment Market – By Drug Type

Based on drug type, the global herpes simplex virus (HSV) treatment market is divided into Acyclovir, Valacyclovir, and Famciclovir segments. The Valacyclovir segment held the highest share in the global herpes simplex virus treatment market during 2022. This can be attributed to its cost-effectiveness, wide availability, and remarkable efficacy in inhibiting the replication of the herpes virus within the body, thus effectively managing the symptoms associated with herpes outbreaks. Valacyclovir is particularly favored for its superior absorption rate compared to acyclovir, making it a preferred choice for treating cold sores, as oral acyclovir is susceptible to rapid breakdown by the liver. Also, a study published in the esteemed American Journal of Ophthalmology has demonstrated the comparable effectiveness of a 500 mg valacyclovir dose in preventing the recurrence of HSV eye disease to that of an 800 mg acyclovir dose. Meanwhile, the acyclovir segment is expected to witness fastest growth during the forecast period. This can be attributed to the widespread acceptance of acyclovir as the industry benchmark for the treatment of herpes infections. Also, the market's growth is fueled by the introduction of over-the-counter drugs for infection treatment.

Herpes Simplex Virus (HSV) Treatment Market Share

Global Herpes Simplex Virus (HSV) Treatment Market – By End User

Based on end user, the global herpes simplex virus (HSV) treatment market is divided into Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Providers segments. The hospital pharmacies segment holds the highest share in the global herpes simplex virus treatment market. These pharmacies serve as primary centres for diagnosing and treating patients afflicted with herpes infections, both in developed and developing economies. The growing prevalence of the disease, coupled with a consistent influx of patients into hospitals, is expected to drive the expansion of the hospital pharmacy segment. Also, favorable reimbursement policies and the increasing number of hospitals equipped with pharmacies contribute to its growth. Moreover, the pricing of pharmaceuticals in hospital pharmacies is typically determined through agreements between the pharmaceutical companies and the pharmacies, especially for bulk purchases. This grants hospital pharmacies the flexibility to negotiate purchase prices based on specific hospital requirements and competition among suppliers.

Herpes Simplex Virus (HSV) Treatment Market Analysis

Global Herpes Simplex Virus (HSV) Treatment Market – By Region

The in-depth research report on the Global Herpes Simplex Virus (HSV) Treatment Market covers various country-specific markets across five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America held the highest market share in 2022 due to increased consumption of branded herpes drugs, rising healthcare expenditure, and favorable reimbursement policies. Disease prevalence, a growing geriatric population, and heightened awareness of STDs contributed to the region's market growth. Meanwhile, the Asia Pacific region is projected to witness the fastest growth rate, driven by the expansion of key players, improving healthcare infrastructure, and government initiatives. High herpes prevalence in emerging economies like China and India, along with the adoption of generics and efforts to develop preventive vaccines, further fueled market expansion. The presence of local players in the Asia Pacific region resulted in a fragmented market landscape.

Competitive Landscape

Major players operating in the global herpes simplex virus treatment market include Abbott Laboratories, Pfizer Inc., Amneal Pharmaceuticals Inc., GlaxoSmithKline PLC, Teva Pharmaceuticals Industries Ltd., Glenmark Pharmaceuticals Limited, Fresenius SE & Co. KGaA, Novartis AG, Viatris Inc., and Emcure Pharmaceuticals Limited. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Recent Developments

  • In August 2022 - OTC Zovirax was introduced to the market targeting the treatment of cold sores and blisters resulting from HSV infections.

Scope of the Report

Attributes

Details

Years Considered

Historical Data – 2019–2022

Base Year – 2022

Estimated Year – 2023

Forecast Period – 2023–2029

Facts Covered

Revenue in USD Billion

Market Coverage

North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa (MEA)

Product/ Service Segmentation

Type, Drug Type, Distribution Channel, Region

Key Players

Abbott Laboratories, Pfizer Inc., Amneal Pharmaceuticals Inc., GlaxoSmithKline PLC, Teva Pharmaceuticals Industries Ltd., Glenmark Pharmaceuticals Limited, Fresenius SE & Co. KGaA, Novartis AG, Viatris Inc., Emcure Pharmaceuticals Limited

 

By Type

  • Herpes Simplex Virus-1 Infection

  • Herpes Simplex Virus-2 Infection

By Drug Type

  • Acyclovir

  • Valacyclovir

  • Famciclovir

By Distribution Channel

  • Hospital Pharmacies

  • Drug Store & Retail Pharmacies

  • Online Providers

By Region

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East and Africa

  1. Research Framework
    1. Research Objective
    2. Product Overview
    3. Market Segmentation
  2. Executive Summary
  3. Global Herpes Simplex Virus (HSV) Treatment Market Insights
    1. Industry Value Chain Analysis
    2. DROC Analysis
      1. Growth Drivers
        1. Increasing prevalence of herpes simplex virus infections
        2. Rising development of HSV testing and medications
      2. Restraints
        1. Prevalent side effects of most used herpes medications
      3. Opportunities
        1. Increase in R&D activities
        2. High growth potential in developing economies
      4. Challenges
        1. Stigma associated with herpes simplex virus
    3. Technological Advancements/Recent Developments
    4. Regulatory Framework
    5. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
    6. Price Point Analysis: Global Automotive Memory, 2019–2022
  4. Global Herpes Simplex Virus (HSV) Treatment Market Overview
    1. Market Size & Forecast by Value, 2019–2029
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Type
        1. Herpes simplex virus-1 infection
        2. Herpes simplex virus–2 infection
      2. By Drug Type
        1. Acyclovir
        2. Valacyclovir
        3. Famciclovir
      3. By Distribution Channel
        1. Hospital pharmacies
        2. Drug store and retail pharmacies
        3. Online providers
      4. By Region
        1. North America
        2. Europe
        3. Asia Pacific (APAC)
        4. Latin America (LATAM)
        5. Middle East and Africa (MEA)
  5. North America Herpes Simplex Virus (HSV) Treatment Market
    1. Market Size & Forecast by Value, 2019–2029
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Type
      2. By Drug Type
      3. By Distribution Channel
      4. By Country
        1. United States
          1. By Type
          2. By Drug Type
          3. By Distribution Channel
        2. Canada
          1. By Type
          2. By Drug Type
          3. By Distribution Channel
  6. Europe Herpes Simplex Virus (HSV) Treatment Market
    1. Market Size & Forecast by Value, 2019–2029
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Type
      2. By Drug Type
      3. By Distribution Channel
      4. By Country
        1. Germany
          1. By Type
          2. By Drug Type
          3. By Distribution Channel
        2. United Kingdom
          1. By Type
          2. By Drug Type
          3. By Distribution Channel
        3. Italy
          1. By Type
          2. By Drug Type
          3. By Distribution Channel
        4. France
          1. By Type
          2. By Drug Type
          3. By Distribution Channel
        5. Spain
          1. By Type
          2. By Drug Type
          3. By Distribution Channel
        6. The Netherlands
          1. By Type
          2. By Drug Type
          3. By Distribution Channel
        7. Rest of Europe
          1. By Type
          2. By Drug Type
          3. By Distribution Channel
  7. Asia-Pacific Herpes Simplex Virus (HSV) Treatment Market
    1. Market Size & Forecast by Value, 2019–2029
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Type
      2. By Drug Type
      3. By Distribution Channel
      4. By Country
        1. China
          1. By Type
          2. By Drug Type
          3. By Distribution Channel
        2. India
          1. By Type
          2. By Drug Type
          3. By Distribution Channel
        3. Japan
          1. By Type
          2. By Drug Type
          3. By Distribution Channel
        4. South Korea
          1. By Type
          2. By Drug Type
          3. By Distribution Channel
        5. Australia & New Zealand
          1. By Type
          2. By Drug Type
          3. By Distribution Channel
        6. Indonesia
          1. By Type
          2. By Drug Type
          3. By Distribution Channel
        7. Malaysia
          1. By Type
          2. By Drug Type
          3. By Distribution Channel
        8. Singapore
          1. By Type
          2. By Drug Type
          3. By Distribution Channel
        9. Philippines
          1. By Type
          2. By Drug Type
          3. By Distribution Channel
        10. Vietnam
          1. By Type
          2. By Drug Type
          3. By Distribution Channel
        11. Rest of APAC
          1. By Type
          2. By Drug Type
          3. By Distribution Channel
  8. Latin America Herpes Simplex Virus (HSV) Treatment Market
    1. Market Size & Forecast by Value, 2019–2029
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Type
      2. By Drug Type
      3. By Distribution Channel
      4. By Country
        1. Brazil
          1. By Type
          2. By Drug Type
          3. By Distribution Channel
        2. Mexico
          1. By Type
          2. By Drug Type
          3. By Distribution Channel
        3. Argentina
          1. By Type
          2. By Drug Type
          3. By Distribution Channel
        4. Peru
          1. By Type
          2. By Drug Type
          3. By Distribution Channel
        5. Colombia
          1. By Type
          2. By Drug Type
          3. By Distribution Channel
        6. Rest of LATAM
          1. By Type
          2. By Drug Type
          3. By Distribution Channel
  9.  Middle East & Africa Herpes Simplex Virus (HSV) Treatment Market
    1. Market Size & Forecast by Value, 2019–2029
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Type
      2. By Drug Type
      3. By Distribution Channel
      4. By Country
        1. Saudi Arabia
          1. By Type
          2. By Drug Type
          3. By Distribution Channel
        2. UAE
          1. By Type
          2. By Drug Type
          3. By Distribution Channel
        3. Qatar
          1. By Type
          2. By Drug Type
          3. By Distribution Channel
        4. Kuwait
          1. By Type
          2. By Drug Type
          3. By Distribution Channel
        5. South Africa
          1. By Type
          2. By Drug Type
          3. By Distribution Channel
        6. Nigeria
          1. By Type
          2. By Drug Type
          3. By Distribution Channel
        7. Algeria
          1. By Type
          2. By Drug Type
          3. By Distribution Channel
        8. Rest of MEA
          1. By Type
          2. By Drug Type
          3. By Distribution Channel
  10. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. Global Herpes Simplex Virus (HSV) Treatment Products Company Market Share Analysis, 2022
    3. Competitive Benchmarking, By Operating Parameters
    4. Key Strategic Development (Mergers, Acquisitions, Partnerships, etc.)
  11. Impact of Covid-19 on Global Herpes Simplex Virus (HSV) Treatment Market
  12. Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook and SWOT Analysis)
    1. Abbott Laboratories
    2. Pfizer, Inc.
    3. Amneal Pharmaceuticals, Inc.
    4. GlaxoSmithKline PLC
    5. Teva Pharmaceuticals Industries Ltd.
    6. Glenmark Pharmaceuticals Limited
    7. Fresenius SE & Co. KGaA
    8. Novartis AG
    9. Viatris, Inc.
    10. Emcure Pharmaceuticals Limited
    11. Other Prominent Players
  13. Key Strategic Recommendations
  14. Research Methodology
    1. Qualitative Research
      1. Primary & Secondary Research
    2. Quantitative Research
    3. Market Breakdown & Data Triangulation
      1. Secondary Research
      2. Primary Research
    4. Breakdown of Primary Research Respondents, By Region
    5. Assumption & Limitation

 

*Financial information of non-listed companies will be provided as per availability

**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable

 

List of Figures

Figure 1    Global Herpes Simplex Virus (HSV) Treatment Market Segmentation

Figure 2    Global Herpes Simplex Virus (HSV) Treatment Market Value Chain Analysis

Figure 3    Company Market Share Analysis, 2022

Figure 4    Global Herpes Simplex Virus (HSV) Treatment Market Size, By Value (USD Billion), 2019–2029

Figure 5    Global Herpes Simplex Virus (HSV) Treatment Market Share, By Type, By Value, 2019–2029

Figure 6    Global Herpes Simplex Virus (HSV) Treatment Market Share, By Drug Type, By Value, 2019–2029

Figure 7    Global Herpes Simplex Virus (HSV) Treatment Market Share, By Distribution Channel, By Value, 2019–2029

Figure 8    Global Herpes Simplex Virus (HSV) Treatment Market Share, By Region, By Value, 2019–2029

Figure 9    North America Herpes Simplex Virus (HSV) Treatment Market Size, By Value (USD Billion), 2019–2029

Figure 10  North America Herpes Simplex Virus (HSV) Treatment Market Share, By Type, By Value, 2019–2029

Figure 11  North America Herpes Simplex Virus (HSV) Treatment Market Share, By Drug Type, By Value, 2019–2029

Figure 12  North America Herpes Simplex Virus (HSV) Treatment Market Share, By Distribution Channel, By Value, 2019–2029

Figure 13  North America Herpes Simplex Virus (HSV) Treatment Market Share, By Country, By Value, 2019–2029

Figure 14  United States Herpes Simplex Virus (HSV) Treatment Market Size, By Value (USD Billion), 2019–2029

Figure 15  United States Herpes Simplex Virus (HSV) Treatment Market Share, By Type, By Value, 2019–2029

Figure 16  United States Herpes Simplex Virus (HSV) Treatment Market Share, By Drug Type, By Value, 2019–2029

Figure 17  United States Herpes Simplex Virus (HSV) Treatment Market Share, By Distribution Channel, By Value, 2019–2029

Figure 18  Canada Herpes Simplex Virus (HSV) Treatment Market Size, By Value (USD Billion), 2019–2029

Figure 19  Canada Herpes Simplex Virus (HSV) Treatment Market Share, By Type, By Value, 2019–2029

Figure 20  Canada Herpes Simplex Virus (HSV) Treatment Market Share, By Drug Type, By Value, 2019–2029

Figure 21  Canada Herpes Simplex Virus (HSV) Treatment Market Share, By Distribution Channel, By Value, 2019–2029

Figure 22  Europe Herpes Simplex Virus (HSV) Treatment Market Size, By Value (USD Billion), 2019–2029

Figure 23  Europe Herpes Simplex Virus (HSV) Treatment Market Share, By Type, By Value, 2019–2029

Figure 24  Europe Herpes Simplex Virus (HSV) Treatment Market Share, By Drug Type, By Value, 2019–2029

Figure 25  Europe Herpes Simplex Virus (HSV) Treatment Market Share, By Distribution Channel, By Value, 2019–2029

Figure 26  Europe Herpes Simplex Virus (HSV) Treatment Market Share, By Country, By Value, 2019–2029

Figure 27  Germany Herpes Simplex Virus (HSV) Treatment Market Size, By Value (USD Billion), 2019–2029

Figure 28  Germany Herpes Simplex Virus (HSV) Treatment Market Share, By Type, By Value, 2019–2029

Figure 29  Germany Herpes Simplex Virus (HSV) Treatment Market Share, By Drug Type, By Value, 2019–2029

Figure 30  Germany Herpes Simplex Virus (HSV) Treatment Market Share, By Distribution Channel, By Value, 2019–2029

Figure 31  United Kingdom Herpes Simplex Virus (HSV) Treatment Market Size, By Value (USD Billion), 2019–2029

Figure 32  United Kingdom Herpes Simplex Virus (HSV) Treatment Market Share, By Type, By Value, 2019–2029

Figure 33  United Kingdom Herpes Simplex Virus (HSV) Treatment Market Share, By Drug Type, By Value, 2019–2029

Figure 34  United Kingdom Herpes Simplex Virus (HSV) Treatment Market Share, By Distribution Channel, By Value, 2019–2029

Figure 35  Italy Herpes Simplex Virus (HSV) Treatment Market Size, By Value (USD Billion), 2019–2029

Figure 36  Italy Herpes Simplex Virus (HSV) Treatment Market Share, By Type, By Value, 2019–2029

Figure 37  Italy Herpes Simplex Virus (HSV) Treatment Market Share, By Drug Type, By Value, 2019–2029

Figure 38  Italy Herpes Simplex Virus (HSV) Treatment Market Share, By Distribution Channel, By Value, 2019–2029

Figure 39  France Herpes Simplex Virus (HSV) Treatment Market Size, By Value (USD Billion), 2019–2029

Figure 40  France Herpes Simplex Virus (HSV) Treatment Market Share, By Type, By Value, 2019–2029

Figure 41  France Herpes Simplex Virus (HSV) Treatment Market Share, By Drug Type, By Value, 2019–2029

Figure 42  France Herpes Simplex Virus (HSV) Treatment Market Share, By Distribution Channel, By Value, 2019–2029

Figure 43  Spain Herpes Simplex Virus (HSV) Treatment Market Size, By Value (USD Billion), 2019–2029

Figure 44  Spain Herpes Simplex Virus (HSV) Treatment Market Share, By Type, By Value, 2019–2029

Figure 45  Spain Herpes Simplex Virus (HSV) Treatment Market Share, By Drug Type, By Value, 2019–2029

Figure 46  Spain Herpes Simplex Virus (HSV) Treatment Market Share, By Distribution Channel, By Value, 2019–2029

Figure 47  The Netherlands Herpes Simplex Virus (HSV) Treatment Market Size, By Value (USD Billion), 2019–2029

Figure 48  The Netherlands Herpes Simplex Virus (HSV) Treatment Market Share, By Type, By Value, 2019–2029

Figure 49  The Netherlands Herpes Simplex Virus (HSV) Treatment Market Share, By Drug Type, By Value, 2019–2029

Figure 50  The Netherlands Herpes Simplex Virus (HSV) Treatment Market Share, By Distribution Channel, By Value, 2019–2029

Figure 51  Rest of Europe Herpes Simplex Virus (HSV) Treatment Market Size, By Value (USD Billion), 2019–2029

Figure 52  Rest of Europe Herpes Simplex Virus (HSV) Treatment Market Share, By Type, By Value, 2019–2029

Figure 53  Rest of Europe Herpes Simplex Virus (HSV) Treatment Market Share, By Drug Type, By Value, 2019–2029

Figure 54  Rest of Europe Herpes Simplex Virus (HSV) Treatment Market Share, By Distribution Channel, By Value, 2019–2029

Figure 55  Asia-Pacific Herpes Simplex Virus (HSV) Treatment Market Size, By Value (USD Billion), 2019–2029

Figure 56  Asia-Pacific Herpes Simplex Virus (HSV) Treatment Market Share, By Type, By Value, 2019–2029

Figure 57  Asia-Pacific Herpes Simplex Virus (HSV) Treatment Market Share, By Drug Type, By Value, 2019–2029

Figure 58  Asia-Pacific Herpes Simplex Virus (HSV) Treatment Market Share, By Distribution Channel, By Value, 2019–2029

Figure 59  Asia-Pacific Herpes Simplex Virus (HSV) Treatment Market Share, By Country, By Value, 2019–2029

Figure 60  China Herpes Simplex Virus (HSV) Treatment Market Size, By Value (USD Billion), 2019–2029

Figure 61  China Herpes Simplex Virus (HSV) Treatment Market Share, By Type, By Value, 2019–2029

Figure 62  China Herpes Simplex Virus (HSV) Treatment Market Share, By Drug Type, By Value, 2019–2029

Figure 63  China Herpes Simplex Virus (HSV) Treatment Market Share, By Distribution Channel, By Value, 2019–2029

Figure 64  India Herpes Simplex Virus (HSV) Treatment Market Size, By Value (USD Billion), 2019–2029

Figure 65  India Herpes Simplex Virus (HSV) Treatment Market Share, By Type, By Value, 2019–2029

Figure 66  India Herpes Simplex Virus (HSV) Treatment Market Share, By Drug Type, By Value, 2019–2029

Figure 67  India Herpes Simplex Virus (HSV) Treatment Market Share, By Distribution Channel, By Value, 2019–2029

Figure 68  Japan Herpes Simplex Virus (HSV) Treatment Market Size, By Value (USD Billion), 2019–2029

Figure 69  Japan Herpes Simplex Virus (HSV) Treatment Market Share, By Type, By Value, 2019–2029

Figure 70  Japan Herpes Simplex Virus (HSV) Treatment Market Share, By Drug Type, By Value, 2019–2029

Figure 71  Japan Herpes Simplex Virus (HSV) Treatment Market Share, By Distribution Channel, By Value, 2019–2029

Figure 72  South Korea Herpes Simplex Virus (HSV) Treatment Market Size, By Value (USD Billion), 2019–2029

Figure 73  South Korea Herpes Simplex Virus (HSV) Treatment Market Share, By Type, By Value, 2019–2029

Figure 74  South Korea Herpes Simplex Virus (HSV) Treatment Market Share, By Drug Type, By Value, 2019–2029

Figure 75  South Korea Herpes Simplex Virus (HSV) Treatment Market Share, By Distribution Channel, By Value, 2019–2029

Figure 76  Australia & New Zealand Herpes Simplex Virus (HSV) Treatment Market Size, By Value (USD Billion), 2019–2029

Figure 77  Australia & New Zealand Herpes Simplex Virus (HSV) Treatment Market Share, By Type, By Value, 2019–2029

Figure 78  Australia & New Zealand Herpes Simplex Virus (HSV) Treatment Market Share, By Drug Type, By Value, 2019–2029

Figure 79  Australia & New Zealand Herpes Simplex Virus (HSV) Treatment Market Share, By Distribution Channel, By Value, 2019–2029

Figure 80  Indonesia Herpes Simplex Virus (HSV) Treatment Market Size, By Value (USD Billion), 2019–2029

Figure 81  Indonesia Herpes Simplex Virus (HSV) Treatment Market Share, By Type, By Value, 2019–2029

Figure 82  Indonesia Herpes Simplex Virus (HSV) Treatment Market Share, By Drug Type, By Value, 2019–2029

Figure 83  Indonesia Herpes Simplex Virus (HSV) Treatment Market Share, By Distribution Channel, By Value, 2019–2029

Figure 84  Malaysia Herpes Simplex Virus (HSV) Treatment Market Size, By Value (USD Billion), 2019–2029

Figure 85  Malaysia Herpes Simplex Virus (HSV) Treatment Market Share, By Type, By Value, 2019–2029

Figure 86  Malaysia Herpes Simplex Virus (HSV) Treatment Market Share, By Drug Type, By Value, 2019–2029

Figure 87  Malaysia Herpes Simplex Virus (HSV) Treatment Market Share, By Distribution Channel, By Value, 2019–2029

Figure 88  Singapore Herpes Simplex Virus (HSV) Treatment Market Size, By Value (USD Billion), 2019–2029

Figure 89  Singapore Herpes Simplex Virus (HSV) Treatment Market Share, By Type, By Value, 2019–2029

Figure 90  Singapore Herpes Simplex Virus (HSV) Treatment Market Share, By Drug Type, By Value, 2019–2029

Figure 91  Singapore Herpes Simplex Virus (HSV) Treatment Market Share, By Distribution Channel, By Value, 2019–2029

Figure 92  Philippines Herpes Simplex Virus (HSV) Treatment Market Size, By Value (USD Billion), 2019–2029

Figure 93  Philippines Herpes Simplex Virus (HSV) Treatment Market Share, By Type, By Value, 2019–2029

Figure 94  Philippines Herpes Simplex Virus (HSV) Treatment Market Share, By Drug Type, By Value, 2019–2029

Figure 95  Philippines Herpes Simplex Virus (HSV) Treatment Market Share, By Distribution Channel, By Value, 2019–2029

Figure 96  Vietnam Herpes Simplex Virus (HSV) Treatment Market Size, By Value (USD Billion), 2019–2029

Figure 97  Vietnam Herpes Simplex Virus (HSV) Treatment Market Share, By Type, By Value, 2019–2029

Figure 98  Vietnam Herpes Simplex Virus (HSV) Treatment Market Share, By Drug Type, By Value, 2019–2029

Figure 99  Vietnam Herpes Simplex Virus (HSV) Treatment Market Share, By Distribution Channel, By Value, 2019–2029

Figure 100 Rest of APAC Herpes Simplex Virus (HSV) Treatment Market Size, By Value (USD Billion), 2019–2029

Figure 101 Rest of APAC Herpes Simplex Virus (HSV) Treatment Market Share, By Type, By Value, 2019–2029

Figure 102 Rest of APAC Herpes Simplex Virus (HSV) Treatment Market Share, By Drug Type, By Value, 2019–2029

Figure 103 Rest of APAC Herpes Simplex Virus (HSV) Treatment Market Share, By Distribution Channel, By Value, 2019–2029

Figure 104 Latin America Herpes Simplex Virus (HSV) Treatment Market Size, By Value (USD Billion), 2019–2029

Figure 105 Latin America Herpes Simplex Virus (HSV) Treatment Market Share, By Type, By Value, 2019–2029

Figure 106 Latin America Herpes Simplex Virus (HSV) Treatment Market Share, By Drug Type, By Value, 2019–2029

Figure 107 Latin America Herpes Simplex Virus (HSV) Treatment Market Share, By Distribution Channel, By Value, 2019–2029

Figure 108 Latin America Herpes Simplex Virus (HSV) Treatment Market Share, By Country, By Value, 2019–2029

Figure 109 Brazil Herpes Simplex Virus (HSV) Treatment Market Size, By Value (USD Billion), 2019–2029

Figure 110 Brazil Herpes Simplex Virus (HSV) Treatment Market Share, By Type, By Value, 2019–2029

Figure 111 Brazil Herpes Simplex Virus (HSV) Treatment Market Share, By Drug Type, By Value, 2019–2029

Figure 112 Brazil Herpes Simplex Virus (HSV) Treatment Market Share, By Distribution Channel, By Value, 2019–2029

Figure 113 Mexico Herpes Simplex Virus (HSV) Treatment Market Size, By Value (USD Billion), 2019–2029

Figure 114 Mexico Herpes Simplex Virus (HSV) Treatment Market Share, By Type, By Value, 2019–2029

Figure 115 Mexico Herpes Simplex Virus (HSV) Treatment Market Share, By Drug Type, By Value, 2019–2029

Figure 116 Mexico Herpes Simplex Virus (HSV) Treatment Market Share, By Distribution Channel, By Value, 2019–2029

Figure 117 Argentina Herpes Simplex Virus (HSV) Treatment Market Size, By Value (USD Billion), 2019–2029

Figure 118 Argentina Herpes Simplex Virus (HSV) Treatment Market Share, By Type, By Value, 2019–2029

Figure 119 Argentina Herpes Simplex Virus (HSV) Treatment Market Share, By Drug Type, By Value, 2019–2029

Figure 120 Argentina Herpes Simplex Virus (HSV) Treatment Market Share, By Distribution Channel, By Value, 2019–2029

Figure 121 Peru Herpes Simplex Virus (HSV) Treatment Market Size, By Value (USD Billion), 2019–2029

Figure 122 Peru Herpes Simplex Virus (HSV) Treatment Market Share, By Type, By Value, 2019–2029

Figure 123 Peru Herpes Simplex Virus (HSV) Treatment Market Share, By Drug Type, By Value, 2019–2029

Figure 124 Peru Herpes Simplex Virus (HSV) Treatment Market Share, By Distribution Channel, By Value, 2019–2029

Figure 125 Colombia Herpes Simplex Virus (HSV) Treatment Market Size, By Value (USD Billion), 2019–2029

Figure 126 Colombia Herpes Simplex Virus (HSV) Treatment Market Share, By Type, By Value, 2019–2029

Figure 127 Colombia Herpes Simplex Virus (HSV) Treatment Market Share, By Drug Type, By Value, 2019–2029

Figure 128 Colombia Herpes Simplex Virus (HSV) Treatment Market Share, By Distribution Channel, By Value, 2019–2029

Figure 129 Rest of LATAM Herpes Simplex Virus (HSV) Treatment Market Size, By Value (USD Billion), 2019–2029

Figure 130 Rest of LATAM Herpes Simplex Virus (HSV) Treatment Market Share, By Type, By Value, 2019–2029

Figure 131 Rest of LATAM Herpes Simplex Virus (HSV) Treatment Market Share, By Drug Type, By Value, 2019–2029

Figure 132 Rest of LATAM Herpes Simplex Virus (HSV) Treatment Market Share, By Distribution Channel, By Value, 2019–2029

Figure 133 Middle East & Africa Herpes Simplex Virus (HSV) Treatment Market Size, By Value (USD Billion), 2019–2029

Figure 134 Middle East & Africa Herpes Simplex Virus (HSV) Treatment Market Share, By Type, By Value, 2019–2029

Figure 135 Middle East & Africa Herpes Simplex Virus (HSV) Treatment Market Share, By Drug Type, By Value, 2019–2029

Figure 136 Middle East & Africa Herpes Simplex Virus (HSV) Treatment Market Share, By Distribution Channel, By Value, 2019–2029

Figure 137 Middle East & Africa Herpes Simplex Virus (HSV) Treatment Market Share, By Country, By Value, 2019–2029

Figure 138 Saudi Arabia Herpes Simplex Virus (HSV) Treatment Market Size, By Value (USD Billion), 2019–2029

Figure 139 Saudi Arabia Herpes Simplex Virus (HSV) Treatment Market Share, By Type, By Value, 2019–2029

Figure 140 Saudi Arabia Herpes Simplex Virus (HSV) Treatment Market Share, By Drug Type, By Value, 2019–2029

Figure 141 Saudi Arabia Herpes Simplex Virus (HSV) Treatment Market Share, By Distribution Channel, By Value, 2019–2029

Figure 142 UAE Herpes Simplex Virus (HSV) Treatment Market Size, By Value (USD Billion), 2019–2029

Figure 143 UAE Herpes Simplex Virus (HSV) Treatment Market Share, By Type, By Value, 2019–2029

Figure 144 UAE Herpes Simplex Virus (HSV) Treatment Market Share, By Drug Type, By Value, 2019–2029

Figure 145 UAE Herpes Simplex Virus (HSV) Treatment Market Share, By Distribution Channel, By Value, 2019–2029

Figure 146 Qatar Herpes Simplex Virus (HSV) Treatment Market Size, By Value (USD Billion), 2019–2029

Figure 147 Qatar Herpes Simplex Virus (HSV) Treatment Market Share, By Type, By Value, 2019–2029

Figure 148 Qatar Herpes Simplex Virus (HSV) Treatment Market Share, By Drug Type, By Value, 2019–2029

Figure 149 Qatar Herpes Simplex Virus (HSV) Treatment Market Share, By Distribution Channel, By Value, 2019–2029

Figure 150 Kuwait Herpes Simplex Virus (HSV) Treatment Market Size, By Value (USD Billion), 2019–2029

Figure 151 Kuwait Herpes Simplex Virus (HSV) Treatment Market Share, By Type, By Value, 2019–2029

Figure 152 Kuwait Herpes Simplex Virus (HSV) Treatment Market Share, By Drug Type, By Value, 2019–2029

Figure 153 Kuwait Herpes Simplex Virus (HSV) Treatment Market Share, By Distribution Channel, By Value, 2019–2029

Figure 154 South Africa Herpes Simplex Virus (HSV) Treatment Market Size, By Value (USD Billion), 2019–2029

Figure 155 South Africa Herpes Simplex Virus (HSV) Treatment Market Share, By Type, By Value, 2019–2029

Figure 156 South Africa Herpes Simplex Virus (HSV) Treatment Market Share, By Drug Type, By Value, 2019–2029

Figure 157 South Africa Herpes Simplex Virus (HSV) Treatment Market Share, By Distribution Channel, By Value, 2019–2029

Figure 158 Nigeria Herpes Simplex Virus (HSV) Treatment Market Size, By Value (USD Billion), 2019–2029

Figure 159 Nigeria Herpes Simplex Virus (HSV) Treatment Market Share, By Type, By Value, 2019–2029

Figure 160 Nigeria Herpes Simplex Virus (HSV) Treatment Market Share, By Drug Type, By Value, 2019–2029

Figure 161 Nigeria Herpes Simplex Virus (HSV) Treatment Market Share, By Distribution Channel, By Value, 2019–2029

Figure 162 Algeria Herpes Simplex Virus (HSV) Treatment Market Size, By Value (USD Billion), 2019–2029

Figure 163 Algeria Herpes Simplex Virus (HSV) Treatment Market Share, By Type, By Value, 2019–2029

Figure 164 Algeria Herpes Simplex Virus (HSV) Treatment Market Share, By Drug Type, By Value, 2019–2029

Figure 165 Algeria Herpes Simplex Virus (HSV) Treatment Market Share, By Distribution Channel, By Value, 2019–2029

Figure 166 Rest of MEA Herpes Simplex Virus (HSV) Treatment Market Size, By Value (USD Billion), 2019–2029

Figure 167 Rest of MEA Herpes Simplex Virus (HSV) Treatment Market Share, By Type, By Value, 2019–2029

Figure 168 Rest of MEA Herpes Simplex Virus (HSV) Treatment Market Share, By Drug Type, By Value, 2019–2029

Figure 169 Rest of MEA Herpes Simplex Virus (HSV) Treatment Market Share, By Distribution Channel, By Value, 2019–2029

 

List of Tables

Table 1      Global Herpes Simplex Virus (HSV) Treatment Market Size, By Type, By Value, 2019–2029

Table 2      Global Herpes Simplex Virus (HSV) Treatment Market Size, By Drug Type, By Value, 2019–2029

Table 3      Global Herpes Simplex Virus (HSV) Treatment Market Size, By Distribution Channel, By Value, 2019–2029

Table 4      Global Herpes Simplex Virus (HSV) Treatment Market Size, By Region, By Value, 2019–2029

Table 5      North America Herpes Simplex Virus (HSV) Treatment Market Size, By Type, By Value, 2019–2029

Table 6      North America Herpes Simplex Virus (HSV) Treatment Market Size, By Drug Type, By Value, 2019–2029

Table 7      North America Herpes Simplex Virus (HSV) Treatment Market Size, By Distribution Channel, By Value, 2019–2029

Table 8      North America Herpes Simplex Virus (HSV) Treatment Market Size, By Country, By Value, 2019–2029

Table 9      United States Herpes Simplex Virus (HSV) Treatment Market Size, By Type, By Value, 2019–2029

Table 10    United States Herpes Simplex Virus (HSV) Treatment Market Size, By Drug Type, By Value, 2019–2029

Table 11    United States Herpes Simplex Virus (HSV) Treatment Market Size, By Distribution Channel, By Value, 2019–2029

Table 12    Canada Herpes Simplex Virus (HSV) Treatment Market Size, By Type, By Value, 2019–2029

Table 13    Canada Herpes Simplex Virus (HSV) Treatment Market Size, By Drug Type, By Value, 2019–2029

Table 14    Canada Herpes Simplex Virus (HSV) Treatment Market Size, By Distribution Channel, By Value, 2019–2029

Table 15    Europe Herpes Simplex Virus (HSV) Treatment Market Size, By Type, By Value, 2019–2029

Table 16    Europe Herpes Simplex Virus (HSV) Treatment Market Size, By Drug Type, By Value, 2019–2029

Table 17    Europe Herpes Simplex Virus (HSV) Treatment Market Size, By Distribution Channel, By Value, 2019–2029

Table 18    Europe Herpes Simplex Virus (HSV) Treatment Market Size, By Country, By Value, 2019–2029

Table 19    Germany Herpes Simplex Virus (HSV) Treatment Market Size, By Type, By Value, 2019–2029

Table 20    Germany Herpes Simplex Virus (HSV) Treatment Market Size, By Drug Type, By Value, 2019–2029

Table 21    Germany Herpes Simplex Virus (HSV) Treatment Market Size, By Distribution Channel, By Value, 2019–2029

Table 22    United Kingdom Herpes Simplex Virus (HSV) Treatment Market Size, By Type, By Value, 2019–2029

Table 23    United Kingdom Herpes Simplex Virus (HSV) Treatment Market Size, By Drug Type, By Value, 2019–2029

Table 24    United Kingdom Herpes Simplex Virus (HSV) Treatment Market Size, By Distribution Channel, By Value, 2019–2029

Table 25    Italy Herpes Simplex Virus (HSV) Treatment Market Size, By Type, By Value, 2019–2029

Table 26    Italy Herpes Simplex Virus (HSV) Treatment Market Size, By Drug Type, By Value, 2019–2029

Table 27    Italy Herpes Simplex Virus (HSV) Treatment Market Size, By Distribution Channel, By Value, 2019–2029

Table 28    France Herpes Simplex Virus (HSV) Treatment Market Size, By Type, By Value, 2019–2029

Table 29    France Herpes Simplex Virus (HSV) Treatment Market Size, By Drug Type, By Value, 2019–2029

Table 30    France Herpes Simplex Virus (HSV) Treatment Market Size, By Distribution Channel, By Value, 2019–2029

Table 31    Spain Herpes Simplex Virus (HSV) Treatment Market Size, By Type, By Value, 2019–2029

Table 32    Spain Herpes Simplex Virus (HSV) Treatment Market Size, By Drug Type, By Value, 2019–2029

Table 33    Spain Herpes Simplex Virus (HSV) Treatment Market Size, By Distribution Channel, By Value, 2019–2029

Table 34    The Netherlands Herpes Simplex Virus (HSV) Treatment Market Size, By Type, By Value, 2019–2029

Table 35    The Netherlands Herpes Simplex Virus (HSV) Treatment Market Size, By Drug Type, By Value, 2019–2029

Table 36    The Netherlands Herpes Simplex Virus (HSV) Treatment Market Size, By Distribution Channel, By Value, 2019–2029

Table 37    Rest of Europe Herpes Simplex Virus (HSV) Treatment Market Size, By Type, By Value, 2019–2029

Table 38    Rest of Europe Herpes Simplex Virus (HSV) Treatment Market Size, By Drug Type, By Value, 2019–2029

Table 39    Rest of Europe Herpes Simplex Virus (HSV) Treatment Market Size, By Distribution Channel, By Value, 2019–2029

Table 40    Asia-Pacific Herpes Simplex Virus (HSV) Treatment Market Size, By Type, By Value, 2019–2029

Table 41    Asia-Pacific Herpes Simplex Virus (HSV) Treatment Market Size, By Drug Type, By Value, 2019–2029

Table 42    Asia-Pacific Herpes Simplex Virus (HSV) Treatment Market Size, By Distribution Channel, By Value, 2019–2029

Table 43    Asia-Pacific Herpes Simplex Virus (HSV) Treatment Market Size, By Country, By Value, 2019–2029

Table 44    China Herpes Simplex Virus (HSV) Treatment Market Size, By Type, By Value, 2019–2029

Table 45    China Herpes Simplex Virus (HSV) Treatment Market Size, By Drug Type, By Value, 2019–2029

Table 46    China Herpes Simplex Virus (HSV) Treatment Market Size, By Distribution Channel, By Value, 2019–2029

Table 47    India Herpes Simplex Virus (HSV) Treatment Market Size, By Type, By Value, 2019–2029

Table 48    India Herpes Simplex Virus (HSV) Treatment Market Size, By Drug Type, By Value, 2019–2029

Table 49    India Herpes Simplex Virus (HSV) Treatment Market Size, By Distribution Channel, By Value, 2019–2029

Table 50    Japan Herpes Simplex Virus (HSV) Treatment Market Size, By Type, By Value, 2019–2029

Table 51    Japan Herpes Simplex Virus (HSV) Treatment Market Size, By Drug Type, By Value, 2019–2029

Table 52    Japan Herpes Simplex Virus (HSV) Treatment Market Size, By Distribution Channel, By Value, 2019–2029

Table 53    South Korea Herpes Simplex Virus (HSV) Treatment Market Size, By Type, By Value, 2019–2029

Table 54    South Korea Herpes Simplex Virus (HSV) Treatment Market Size, By Drug Type, By Value, 2019–2029

Table 55    South Korea Herpes Simplex Virus (HSV) Treatment Market Size, By Distribution Channel, By Value, 2019–2029

Table 56    Australia & New Zealand Herpes Simplex Virus (HSV) Treatment Market Size, By Type, By Value, 2019–2029

Table 57    Australia & New Zealand Herpes Simplex Virus (HSV) Treatment Market Size, By Drug Type, By Value, 2019–2029

Table 58    Australia & New Zealand Herpes Simplex Virus (HSV) Treatment Market Size, By Distribution Channel, By Value, 2019–2029

Table 59    Indonesia Herpes Simplex Virus (HSV) Treatment Market Size, By Type, By Value, 2019–2029

Table 60    Indonesia Herpes Simplex Virus (HSV) Treatment Market Size, By Drug Type, By Value, 2019–2029

Table 61    Indonesia Herpes Simplex Virus (HSV) Treatment Market Size, By Distribution Channel, By Value, 2019–2029

Table 62    Malaysia Herpes Simplex Virus (HSV) Treatment Market Size, By Type, By Value, 2019–2029

Table 63    Malaysia Herpes Simplex Virus (HSV) Treatment Market Size, By Drug Type, By Value, 2019–2029

Table 64    Malaysia Herpes Simplex Virus (HSV) Treatment Market Size, By Distribution Channel, By Value, 2019–2029

Table 65    Singapore Herpes Simplex Virus (HSV) Treatment Market Size, By Type, By Value, 2019–2029

Table 66    Singapore Herpes Simplex Virus (HSV) Treatment Market Size, By Drug Type, By Value, 2019–2029

Table 67    Singapore Herpes Simplex Virus (HSV) Treatment Market Size, By Distribution Channel, By Value, 2019–2029

Table 68    Philippines Herpes Simplex Virus (HSV) Treatment Market Size, By Type, By Value, 2019–2029

Table 69    Philippines Herpes Simplex Virus (HSV) Treatment Market Size, By Drug Type, By Value, 2019–2029

Table 70    Philippines Herpes Simplex Virus (HSV) Treatment Market Size, By Distribution Channel, By Value, 2019–2029

Table 71    Vietnam Herpes Simplex Virus (HSV) Treatment Market Size, By Type, By Value, 2019–2029

Table 72    Vietnam Herpes Simplex Virus (HSV) Treatment Market Size, By Drug Type, By Value, 2019–2029

Table 73    Vietnam Herpes Simplex Virus (HSV) Treatment Market Size, By Distribution Channel, By Value, 2019–2029

Table 74    Rest of APAC Herpes Simplex Virus (HSV) Treatment Market Size, By Type, By Value, 2019–2029

Table 75    Rest of APAC Herpes Simplex Virus (HSV) Treatment Market Size, By Drug Type, By Value, 2019–2029

Table 76    Rest of APAC Herpes Simplex Virus (HSV) Treatment Market Size, By Distribution Channel, By Value, 2019–2029

Table 77    Latin America Herpes Simplex Virus (HSV) Treatment Market Size, By Type, By Value, 2019–2029

Table 78    Latin America Herpes Simplex Virus (HSV) Treatment Market Size, By Drug Type, By Value, 2019–2029

Table 79    Latin America Herpes Simplex Virus (HSV) Treatment Market Size, By Distribution Channel, By Value, 2019–2029

Table 80    Latin America Herpes Simplex Virus (HSV) Treatment Market Size, By Country, By Value, 2019–2029

Table 81    Brazil Herpes Simplex Virus (HSV) Treatment Market Size, By Type, By Value, 2019–2029

Table 82    Brazil Herpes Simplex Virus (HSV) Treatment Market Size, By Drug Type, By Value, 2019–2029

Table 83    Brazil Herpes Simplex Virus (HSV) Treatment Market Size, By Distribution Channel, By Value, 2019–2029

Table 84    Mexico Herpes Simplex Virus (HSV) Treatment Market Size, By Type, By Value, 2019–2029

Table 85    Mexico Herpes Simplex Virus (HSV) Treatment Market Size, By Drug Type, By Value, 2019–2029

Table 86    Mexico Herpes Simplex Virus (HSV) Treatment Market Size, By Distribution Channel, By Value, 2019–2029

Table 87    Argentina Herpes Simplex Virus (HSV) Treatment Market Size, By Type, By Value, 2019–2029

Table 88    Argentina Herpes Simplex Virus (HSV) Treatment Market Size, By Drug Type, By Value, 2019–2029

Table 89    Argentina Herpes Simplex Virus (HSV) Treatment Market Size, By Distribution Channel, By Value, 2019–2029

Table 90    Peru Herpes Simplex Virus (HSV) Treatment Market Size, By Type, By Value, 2019–2029

Table 91    Peru Herpes Simplex Virus (HSV) Treatment Market Size, By Drug Type, By Value, 2019–2029

Table 92    Peru Herpes Simplex Virus (HSV) Treatment Market Size, By Distribution Channel, By Value, 2019–2029

Table 93    Colombia Herpes Simplex Virus (HSV) Treatment Market Size, By Type, By Value, 2019–2029

Table 94    Colombia Herpes Simplex Virus (HSV) Treatment Market Size, By Drug Type, By Value, 2019–2029

Table 95    Colombia Herpes Simplex Virus (HSV) Treatment Market Size, By Distribution Channel, By Value, 2019–2029

Table 96    Rest of LATAM Herpes Simplex Virus (HSV) Treatment Market Size, By Type, By Value, 2019–2029

Table 97    Rest of LATAM Herpes Simplex Virus (HSV) Treatment Market Size, By Drug Type, By Value, 2019–2029

Table 98    Rest of LATAM Herpes Simplex Virus (HSV) Treatment Market Size, By Distribution Channel, By Value, 2019–2029

Table 99    Middle East & Africa Herpes Simplex Virus (HSV) Treatment Market Size, By Type, By Value, 2019–2029

Table 100  Middle East & Africa Herpes Simplex Virus (HSV) Treatment Market Size, By Drug Type, By Value, 2019–2029

Table 101  Middle East & Africa Herpes Simplex Virus (HSV) Treatment Market Size, By Distribution Channel, By Value, 2019–2029

Table 102  Middle East & Africa Herpes Simplex Virus (HSV) Treatment Market Size, By Country, By Value, 2019–2029

Table 103  Saudi Arabia Herpes Simplex Virus (HSV) Treatment Market Size, By Type, By Value, 2019–2029

Table 104  Saudi Arabia Herpes Simplex Virus (HSV) Treatment Market Size, By Drug Type, By Value, 2019–2029

Table 105  Saudi Arabia Herpes Simplex Virus (HSV) Treatment Market Size, By Distribution Channel, By Value, 2019–2029

Table 106  UAE Herpes Simplex Virus (HSV) Treatment Market Size, By Type, By Value, 2019–2029

Table 107  UAE Herpes Simplex Virus (HSV) Treatment Market Size, By Drug Type, By Value, 2019–2029

Table 108  UAE Herpes Simplex Virus (HSV) Treatment Market Size, By Distribution Channel, By Value, 2019–2029

Table 109  Qatar Herpes Simplex Virus (HSV) Treatment Market Size, By Type, By Value, 2019–2029

Table 110  Qatar Herpes Simplex Virus (HSV) Treatment Market Size, By Drug Type, By Value, 2019–2029

Table 111  Qatar Herpes Simplex Virus (HSV) Treatment Market Size, By Distribution Channel, By Value, 2019–2029

Table 112  Kuwait Herpes Simplex Virus (HSV) Treatment Market Size, By Type, By Value, 2019–2029

Table 113  Kuwait Herpes Simplex Virus (HSV) Treatment Market Size, By Drug Type, By Value, 2019–2029

Table 114  Kuwait Herpes Simplex Virus (HSV) Treatment Market Size, By Distribution Channel, By Value, 2019–2029

Table 115  South Africa Herpes Simplex Virus (HSV) Treatment Market Size, By Type, By Value, 2019–2029

Table 116  South Africa Herpes Simplex Virus (HSV) Treatment Market Size, By Drug Type, By Value, 2019–2029

Table 117  South Africa Herpes Simplex Virus (HSV) Treatment Market Size, By Distribution Channel, By Value, 2019–2029

Table 118  Nigeria Herpes Simplex Virus (HSV) Treatment Market Size, By Type, By Value, 2019–2029

Table 119  Nigeria Herpes Simplex Virus (HSV) Treatment Market Size, By Drug Type, By Value, 2019–2029

Table 120  Nigeria Herpes Simplex Virus (HSV) Treatment Market Size, By Distribution Channel, By Value, 2019–2029

Table 121  Algeria Herpes Simplex Virus (HSV) Treatment Market Size, By Type, By Value, 2019–2029

Table 122  Algeria Herpes Simplex Virus (HSV) Treatment Market Size, By Drug Type, By Value, 2019–2029

Table 123  Algeria Herpes Simplex Virus (HSV) Treatment Market Size, By Distribution Channel, By Value, 2019–2029

Table 124  Rest of MEA Herpes Simplex Virus (HSV) Treatment Market Size, By Type, By Value, 2019–2029

Table 125  Rest of MEA Herpes Simplex Virus (HSV) Treatment Market Size, By Drug Type, By Value, 2019–2029

Table 126  Rest of MEA Herpes Simplex Virus (HSV) Treatment Market Size, By Distribution Channel, By Value, 2019–2029

Table 127  Abbott Laboratories Company Overview

Table 128  Abbott Laboratories Financial Overview

Table 129  Pfizer, Inc. Company Overview

Table 130  Pfizer, Inc. Financial Overview

Table 131  Amneal Pharmaceuticals, Inc. Company Overview

Table 132  Amneal Pharmaceuticals, Inc. Financial Overview

Table 133  GlaxoSmithKline PLC Company Overview

Table 134  GlaxoSmithKline PLC Financial Overview

Table 135  Teva Pharmaceuticals Industries Ltd. Company Overview

Table 136  Teva Pharmaceuticals Industries Ltd. Financial Overview

Table 137  Glenmark Pharmaceuticals Limited Company Overview

Table 138  Glenmark Pharmaceuticals Limited Financial Overview

Table 139  Fresenius SE & Co. KGaA Company Overview

Table 140  Fresenius SE & Co. KGaA Financial Overview

Table 141  Novartis AG Company Overview

Table 142  Novartis AG Financial Overview

Table 143  Viatris, Inc. Company Overview

Table 144  Viatris, Inc. Financial Overview

Table 145  Emcure Pharmaceuticals Limited Company Overview

Table 146  Emcure Pharmaceuticals Limited Financial Overview

Market Segmentation

No data available
No data available

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

Note: Please share the corporate email address for faster response

This website is secure and your personal details are safe.

Frequently Asked Questions (FAQs):

Ans: The Valacyclovir segment holds the highest market share in the Global Herpes Simplex Virus (HSV) Treatment Market by drug type.
Ans: Global Herpes Simplex Virus (HSV) Treatment Market size was estimated at USD 1.73 billion in 2022.
Ans: Major factors driving the growth of the Global Herpes Simplex Virus (HSV) Treatment Market include increasing prevalence of herpes simplex virus infections and rising development of HSV testing and medications.
Ans: Key players in the Global Herpes Simplex Virus (HSV) Treatment Market include Abbott Laboratories, Pfizer Inc., Amneal Pharmaceuticals Inc., GlaxoSmithKline PLC, Teva Pharmaceuticals Industries Ltd., Glenmark Pharmaceuticals Limited, Fresenius SE & Co. KGaA, Novartis AG, Viatris Inc., and Emcure Pharmaceuticals Limited.
Ans: The Herpes simplex virus-2 infection segment is expected to hold a higher market share in the Global Herpes Simplex Virus (HSV) Treatment Market by type. 
array(1) {
  ["__ci_last_regenerate"]=>
  int(1734940722)
}